Suspecting infringement of patents for its Parkinson’s drug, Xadago, biopharmaceutical company Newron has won preliminary discovery of documents from generic drug maker Arrotex Pharmaceuticals.
The managing director of the Australian arm of property developer Arada has lost his bid to bar a vote on his termination as he and the group’s CEO sling allegations of misconduct and dishonesty.
Two units of builder BGC have won a stay of building remedy orders to re-pipe homes fitted with faulty Iplex piping while they appeal the orders, but have lost a bid to adjourn the appeals.
Owners of apartments in Sydney’s One Central Park have been ordered to pay Frasers’ costs in defending a suit that sought declarations in relation to defective planter boxes on the building’s façade.
Two sacked executives of JLL’s industrial division have filed court action against the publisher of The Australian over articles they say had a “devastating” impact on their reputations and cost them up to $15 million.
Global real estate investment giant Colliers has boosted its presence in South Australia by acquiring a leading Adelaide-based urban development consultancy.
Isuzu has lost an appeal bid to shut down a lawsuit by car alarm company Directed Electronics over alleged trade secrets theft, after an earlier case left it with a $169 million damages bill.
The corporate cop has won court approval to proceed with a consumer suit against debt manager Solve My Debt, despite the company falling into liquidation.
Barry Nilsson has executed on its strategic growth agenda with the recruitment of six new principals and their teams from DLA Piper in a major boost to its insurance and health practice.
CBRE has denied taking unlawful adverse action against an employee who alleges he was forced to continue working with a manager who falsely accused him of killing his rabbit and asked him which female coworkers he would have sex with.